StocksInsight

CHRW Stock vs the S&P 500: Returns, Risk and Crash History

C.H. Robinson Worldwide, Inc., industrials (market value $15.5 billion), an S&P 500 member: how it compared with the S&P 500, how it behaved in every crash since 2008, its risk‑adjusted returns and what analysts said. Returns to Oct 30, 2026; analyst data as of Nov 16, 2026.

Published Updated 4 min readHow we research

What changed since Nov 9

Exent re-checks this page every day. Ratings appear 30 days after they are published; the top‑ranked analysts’ calls are not counted here, they are in Gems.

72% Buy ratings (was 76%)

Key takeaways

  • CHRW returned +43.9% over the 5 years to Oct 30, 2026 versus +75.9% for the S&P 500: it lagged the index.
  • Its 5-year Sharpe ratio was 0.27 against 0.58 for the S&P 500.
  • Its deepest crisis drawdown was −43.4% in the global financial crisis (2007–09) (S&P 500: −56.5%).
  • Five‑year volatility was 34.9% and beta 0.95.
  • 25 analysts rated it in the past year; 72% of their latest calls were Buy.
  • CHRW beat earnings estimates in 11 of its last 12 reports; the stock moved 9.9% on average, up or down, around each report.

What do the best‑ranked analysts on CHRW say now? See it in Exent Gems →

Did CHRW beat the S&P 500?

Over the 5 years to Oct 30, 2026, C.H. Robinson Worldwide, Inc. (CHRW) returned +43.9% including dividends, versus +75.9% for the S&P 500 (SPY). It lagged the index by 32.0 percentage points, or +7.5% a year against +12.0%.

PeriodCHRWS&P 500CHRW per yearS&P 500 per yearResult
1 year−17.8%+12.0%−17.8%+12.0%Lagged
3 years+62.9%+87.4%+17.7%+23.3%Lagged
5 years+43.9%+75.9%+7.5%+12.0%Lagged
10 years+131.2%+316.3%+8.7%+15.3%Lagged
  • 1 year
    CHRW
    −17.8%
    S&P 500
    +12.0%
    CHRW per year
    −17.8%
    S&P 500 per year
    +12.0%
    Result
    Lagged
  • 3 years
    CHRW
    +62.9%
    S&P 500
    +87.4%
    CHRW per year
    +17.7%
    S&P 500 per year
    +23.3%
    Result
    Lagged
  • 5 years
    CHRW
    +43.9%
    S&P 500
    +75.9%
    CHRW per year
    +7.5%
    S&P 500 per year
    +12.0%
    Result
    Lagged
  • 10 years
    CHRW
    +131.2%
    S&P 500
    +316.3%
    CHRW per year
    +8.7%
    S&P 500 per year
    +15.3%
    Result
    Lagged

Total return with dividends reinvested, from month-end prices to Oct 30, 2026. Beating the index on raw return is only half the story: the next section adjusts for the risk taken. See also how to beat the S&P 500.

CHRW is in the S&P 500 (members as of Oct 20, 2026); the list shows every member’s return against the index.

What Wall Street analysts say about CHRW

In the 12 months to 30 days ago, 25 analysts published 259 ratings on CHRW. Their latest calls were 72% Buy, 24% Hold and 4% Sell. 12 of them rank 4★ or higher in Exent’s analyst scoring, which is based on each analyst’s past price‑target hit rate and returns.

The consensus 12‑month price target was $178.25 (range $91.00–$226.00), +29.7% from the last price. Remember that the average analyst’s target is hit only about half the time: how accurate are price targets?

Top‑ranked analyst coveringFirmStarsPrice‑target hit rate
Jason SeidlTD Cowen5.0★55.7%
Ariel RosaCiti5.0★56.8%
??????5.0★56.3%
??????4.9★53.7%
??????4.9★53.7%

Other analysts covering CHRW: Thomas Wadewitz · Bascome Majors · Stephanie Moore · Lucas Servera

Ratings are shown with a 30‑day delay. Who the top‑ranked analysts on CHRW are, their live calls and the median target of only the top‑rated analysts are in Exent Gems.

The average analyst’s target is reached about 53.0% of the time; Exent Gems is built on the top 50 of Exent’s ranking,where some reached 90% or more over the last two years. Unlock the top 50 analysts.

CHRW returns by year vs the S&P 500

CHRW beat the S&P 500 in 5 of the 9 full calendar years shown.

YearCHRWS&P 500Difference
2026 (to Oct 30, 2026)−21.6%+11.7%−33.3%
2025+59.0%+17.7%+41.3%
2024+22.9%+24.9%−2.0%
2023−3.1%+26.2%−29.3%
2022−13.1%−18.2%+5.1%
2021+17.2%+28.7%−11.5%
2020+23.0%+18.3%+4.7%
2019−4.7%+31.2%−35.9%
2018−3.7%−4.6%+0.9%
2017+25.3%+21.7%+3.6%

CHRW risk-adjusted returns: Sharpe, Sortino and volatility

Over 5 years, CHRW had a Sharpe ratio of 0.27 against 0.58 for the S&P 500, so it earned less return per unit of risk than the index. Its annualized volatility was 30.7% and its beta 0.95: it tended to move about 0.9× as much as the market.

MetricCHRWS&P 500
Annual return+7.5%+12.0%
Volatility (annualized)30.7%15.5%
Sharpe ratio0.270.58
Sortino ratio0.420.91
Max drawdown (month-end)−35.4%−23.9%
Beta to the S&P 5000.951.00

Sharpe divides return above cash by total volatility; Sortino counts only downside volatility. Both use monthly returns and the 1–3 month T‑bill ETF (BIL) as the risk‑free rate.

How CHRW behaved in past crashes

CHRW’s deepest fall in the crises below was −43.4% in the global financial crisis (2007–09), against −56.5% for the S&P 500. The last column turns that into money: what a $100,000 position would have lost from peak to trough.

CrisisCHRWS&P 500Loss on $100,000
Global financial crisis (2007–09)−43.4%−56.5%−$43,440
2018 trade-war selloff−19.3%−20.2%−$19,270
COVID crash (Feb–Mar 2020)−19.7%−34.1%−$19,660
2022 inflation bear market−21.3%−25.4%−$21,330
2025 tariff selloff−15.4%−19.0%−$15,420
WindowCHRW max drawdown
Last 1 year−40.2%
Last 3 years−40.2%
Last 5 years−40.6%
Last 10 years−43.2%

Peak‑to‑trough declines from daily prices inside each crisis window. A crash replay does not predict the next crisis; it shows how much room a holding needs. Run the same replay on a whole portfolio with the crash test.

What moves with CHRW, and what doesn’t

Correlation runs from −1 (moves opposite) to +1 (moves in lockstep). Over the last 60 months of monthly returns, CHRW’s correlation with the S&P 500 was 0.48, with the Nasdaq‑100 0.46, with long Treasuries (TLT) 0.29 and with gold (GLD) 0.21.

Adding a 5% CHRW position to an S&P 500 portfolio would have moved its 5‑year volatility from 15.5% to 15.5%.

Least correlated large capsCorrelationMost correlated large capsCorrelation
INTU−0.17CAT0.57
CME−0.16GLW0.52
NOW−0.12WDC0.49
MCK−0.12LRCX0.47
CRM−0.09APH0.46

Holdings that are highly correlated behave like one position in a selloff. See how to find hidden overlap.

Latest CHRW upgrades, downgrades and price‑target changes

DateRating and targetAnalyst
Oct 29Target cut
Buy
Target $183, was $185
Ariel Rosa
Citi
Oct 29Target cut
Hold
Target $145, was $155
Jason Seidl
TD Cowen
Oct 29Target cut
Buy
Target $190, was $215
Bascome Majors
Stephens
Oct 29Target cut
Buy
Target $180, was $200
Lucas Servera
Truist Financial
Oct 15Target cut
Buy
Target $170, was $203
David Hicks CFA
Raymond James
Oct 12Downgrade
Buy → Hold
Target $153, was $220
Richa Harnain
Deutsche Bank
Oct 8Target cut
Buy
Target $209, was $225
J. Bruce Chan
Stifel Nicolaus
Oct 7Target cut
Buy
Target $200, was $215
Lucas Servera
Truist Financial
Oct 6Target cut
Buy
Target $203, was $226
Ken Hoexter
Bank of America Securities
Oct 5Target cut
Buy
Target $198, was $225
Brian Ossenbeck
J.P. Morgan

Named analysts’ rating and price‑target changes on CHRW in the 5 weeks to Oct 20, 2026, shown 30 days after publication (the free analysts’ calls 3 days after). The top‑ranked analysts’ calls are in Exent Gems. See all of the latest analyst upgrades and downgrades.

Do analysts get CHRW right?

Of the 426 analyst price targets on CHRW set from 2019 until a year ago, 79.3% were reached within 12 months (data to Oct 20, 2026), 10.7 points above the 68.6% hit rate of the median stock in Exent’s study of 794 stocks. Targets that were reached took a median of 50 days. The median target sat 4.9% above the share price on the day it was set.

Where analysts said CHRW would be by now: a year ago, 13 analysts had a price target on CHRW, and the median of their latest targets was $163.00. On Oct 20, 2026 CHRW closed at $140.55, 13.8% below it.

79.3%of targets reached within 12 monthsMedian stock: 68.6%
50 daysmedian time to reach a target
−13.8%price now vs the median target set a year ago
AfterCallsMove on the call3 months vs S&P 500
Upgrades of CHRW36+2.2%+6.3%
Upgrades, all stocks11,514+2.5%+3.4%
Downgrades of CHRW28−1.6%−1.0%
Downgrades, all stocks10,700−3.0%−1.6%

The move on the call runs from the close before the rating change to the close after it; the last column is the stock’s return minus the S&P 500’s over the next three months. Averages of rating changes on CHRW through Sep 15, 2026; analysts are not named here. Do analyst upgrades move stocks?

How CHRW moves after earnings

CHRW beat the consensus earnings‑per‑share estimate in 11 of its last 12 quarterly reports, through the one on Jul 29, 2026, and the revenue estimate in 3 of 12. From the close before each report to the close after it, the stock moved 9.9% on average, up or down, against 6.8% for the average report across the 1,002 US stocks Exent tracks. It rose after 6 of the 12 reports. In 5 of the 11 beats the stock still fell.

11/12earnings beats
±9.9%average move per report
6/12reports followed by a rise
ReportEPS vs estimateRevenue vs estimateStock move
Jul 29, 2026$1.61 vs $1.53+13.5%−13.2%
Apr 29, 2026$1.35 vs $1.23−0.8%−3.3%
Jan 28, 2026$1.23 vs $1.12−1.9%+7.4%
Oct 29, 2025$1.40 vs $1.30−2.2%+20.9%
Jul 30, 2025$1.29 vs $1.16−0.8%+15.6%
Apr 30, 2025$1.17 vs $1.05−4.9%+2.2%
Jan 29, 2025$1.21 vs $1.10−5.7%−8.5%
Oct 30, 2024$1.28 vs $1.15+2.6%−4.6%

Reported earnings per share against the consensus estimate, revenue surprise in percent, and the stock’s price change over the two sessions around the report. How stocks move after earnings

Where CHRW’s revenue comes from

In fiscal 2025 (the year to Dec 31, 2025), CHRW’s largest reported region was the United States, with 88.3% of its $16.2 billion revenue. By region: United States 88.3%; Non-US 11.7%.

By business, the largest segment was Transportation Customer’s Freight, with 91.3% of $16.2 billion revenue (−9.4% on the year before).

  • United States88.3%
  • Non-US11.7%
SegmentRevenueShareGrowth
Transportation Customer’s Freight$14.8 billion91.3%−9.4%
Sourcing$1.4 billion8.7%+2.8%

From CHRW’s annual filings; segment growth compares fiscal 2025 with the year before. Regions are as each company reports them, so one company’s “Asia Pacific” is not another’s. China counts the regions a company reports as China, Greater China or Hong Kong; a separately reported Taiwan is not counted. Which S&P 500 companies depend most on China?

Members of Congress who traded CHRW

As of Oct 20, 2026, 5 members of Congress had disclosed 34 trades in CHRW (24 buys and 10 sales) in STOCK Act disclosures filed with the House and Senate. The latest public trade is dated Aug 25, 2026.

Trade dateMemberTypeAmount
Aug 25, 2026John DelaneySale$100,001–$250,000
Aug 14, 2026John DelaneyBuy$1,001–$15,000
Aug 12, 2026John DelaneyBuy$1,001–$15,000
Aug 5, 2026John DelaneyBuy$1,001–$15,000
Aug 3, 2026John DelaneyBuy$15,001–$50,000
Jul 31, 2026John DelaneyBuy$15,001–$50,000
Jul 28, 2026John DelaneyBuy$1,001–$15,000
Jul 27, 2026John DelaneyBuy$15,001–$50,000
Jul 24, 2026John DelaneyBuy$1,001–$15,000
Jul 22, 2026John DelaneyBuy$1,001–$15,000

Amounts are the ranges members report, not exact values. The STOCK Act gives members up to 45 days to disclose a trade, so trades appear weeks after they are made. See every member’s disclosed trades

One trade in CHRW disclosed in the last 30 days is in Exent Radar.

Are CHRW insiders buying or selling?

In the 12 months to Oct 20, 2026, CHRW insiders made 4 open‑market purchases worth $501,637 by 4 insiders and 10 sales worth $18.9 million, according to SEC Form 4 filings.

After the 15 insider purchases of $10,000 or more since 2012, CHRW lagged the S&P 500 by an average of 7.9 percentage points over the next 12 months; 46% of them were followed by a beat. Across all 17,865 insider purchases in Exent’s study, the average was +17.2% and the median +1.0% against the index.

Q4 ’24
Q1 ’25
Q2 ’25
Q3 ’25
Q4 ’25
Q1 ’26
Q2 ’26
Q3 ’26
DateInsiderRoleValue
Feb 12, 2026Castagnetto Michael D.Pres, NAST$100,000
Feb 12, 2026Bozeman David PDirector, officer: President & CEO$199,771
Feb 12, 2026Rajan ArunChief Strat & Innov Officer$101,102
Feb 12, 2026Lee Damon J.Chief Financial Officer$100,764
Nov 14, 2023Bozeman David PDirector, officer: President & CEO$149,818

The table lists the latest open‑market purchases on record, leaving out the last 30 days. The chart counts Form 4 purchases and sales by calendar quarter. Purchases are open‑market buys; sales include planned sales under 10b5‑1 trading plans. Do insider buys beat the market?

How much of CHRW is sold short?

As of the Sep 30, 2026 settlement date, 4.69% of CHRW’s float was sold short: 5.5 million shares, or 3.9 days of average trading volume to cover. A year earlier (Oct 15, 2025) it was 6.60%. The median across the 997 US stocks Exent tracks was 4.77%, so CHRW is less heavily shorted than most.

  • Apr 30, 20266.36%
  • May 29, 20265.94%
  • Jun 30, 20267.03%
  • Jul 31, 20264.71%
  • Aug 31, 20264.01%
  • Sep 30, 20264.69%

From FINRA short‑interest reports, filed twice a month; the bars show the short share of the float at each month‑end. Days to cover divides the shares short by the average daily volume. The most shorted stocks

How many institutions own CHRW?

At the end of Q2 2026 (Jun 30, 2026), 929 institutions reported holding CHRW in 13F filings, up 4 from the quarter before and up from 690 a year earlier. Their reported holdings add up to 101.7% of CHRW’s shares. In the quarter 446 institutions added to their positions and 330 cut them.

92913F holders
123new positions
119positions closed
101.7%of shares held by 13F filers

Investment managers with over $100 million in US equities file 13F reports within 45 days of each quarter end, so this is the latest complete quarter. Holdings can add up to more than 100% when shares are lent and counted twice. Which stocks institutions are buying and selling

Is CHRW diluting shareholders?

CHRW’s diluted share count fell 10.8% over the five fiscal years to fiscal 2025 and rose 0.7% in fiscal 2025 alone. Each share now owns a larger slice of the company. The median change across the 1,005 US stocks Exent tracks was −0.1%.

Stock‑based compensation was $80.1 million in fiscal 2025, 0.5% of revenue. CHRW spent $354.7 million buying back shares, a buyback yield of 1.97% of its market value; stock pay equaled 22.6% of the buybacks.

+0.7%share count, 1 year
−10.8%share count, 5 years
0.5%stock pay as % of revenue
1.97%buyback yield

Weighted‑average diluted shares from CHRW’s annual income statements; stock‑based compensation and buybacks from its cash‑flow statement. Stock dilution and stock‑based compensation, explained

CHRW financial health scores

In Exent’s Oct 20, 2026 snapshot, CHRW’s Altman Z‑score was 7.52, in the safe zone (where 465 of the 794 non‑financial US stocks Exent tracks sit). Its Piotroski F‑score was 8 out of 9; 20% of scored stocks reach 8 or more.

7.52Altman Z‑score: safe zone
8/9Piotroski F‑score

The Altman Z‑score combines five balance‑sheet and earnings ratios into one bankruptcy‑risk score: below 1.81 is the distress zone, 1.81–2.99 grey, above 2.99 safe. It is not meaningful for banks, insurers and REITs. The Piotroski F‑score counts nine yes/no tests of profitability, leverage and efficiency; 8–9 is strong, 0–2 weak. Both come from the latest annual statements. Which stocks have the highest bankruptcy risk?

What CHRW talks about on earnings calls

On its latest earnings call (Jul 29, 2026), CHRW’s executives and analysts mentioned AI 49 times, against 52 on the call before (Apr 29, 2026); the average across 455 S&P 500 calls that quarter was 12.9. After AI, the most mentioned topic was ai agents (8). Tariffs and recession did not come up.

MentionsJul ’26Apr ’26Jan ’26Oct ’25
AI49524458
AI agents8171423
Data centers0000
Tariffs0000
China0000
Recession0011
  • AI
    Jul ’26
    49
    Apr ’26
    52
    Jan ’26
    44
    Oct ’25
    58
  • AI agents
    Jul ’26
    8
    Apr ’26
    17
    Jan ’26
    14
    Oct ’25
    23
  • Data centers
    Jul ’26
    0
    Apr ’26
    0
    Jan ’26
    0
    Oct ’25
    0
  • Tariffs
    Jul ’26
    0
    Apr ’26
    0
    Jan ’26
    0
    Oct ’25
    0
  • China
    Jul ’26
    0
    Apr ’26
    0
    Jan ’26
    0
    Oct ’25
    0
  • Recession
    Jul ’26
    0
    Apr ’26
    0
    Jan ’26
    1
    Oct ’25
    1

Word counts in the full transcript of each call, prepared remarks and Q&A, newest first. “AI” also counts generative AI and large language models; “AI agents” counts agentic AI. Which companies talk most about AI?

Which ETFs hold CHRW?

As of Oct 20, 2026, 54 of the 304 ETFs Exent tracks held CHRW. Its largest weight is in IWP (iShares Russell Mid-Cap Growth ETF), at 0.45% of the fund.

ETFFundWeight of CHRW
IWPiShares Russell Mid-Cap Growth ETF0.45%
SDYState Street SPDR S&P Dividend ETF0.39%
VBRVanguard Small-Cap Value Index Fund ETF Shares0.37%
SCHMSchwab U.S. Mid-Cap ETF0.34%
XLIState Street Industrial Select Sector SPDR ETF0.31%
VISVanguard Industrials Index Fund ETF Shares0.26%
VBVanguard Small-Cap Index Fund ETF Shares0.21%
RSPInvesco S&P 500 Equal Weight ETF0.19%

Owning several of these funds stacks the same position. How much do VOO, QQQ and VTI overlap?

The right benchmark for CHRW

Exent matches every holding to the index with the most similar risk. For CHRW that is SPY (the S&P 500). Comparing a holding with an index that carries very different risk makes good results look bad and risky ones look clever. Read why the S&P 500 is the wrong benchmark for most portfolios.

Other industrials stocks

TickerName5‑year returnVolatility (5y)
SPCXSpace Exploration Technologies Corp.——
GEGE Aerospace+374.0%31.1%
RTXRTX Corporation+150.3%23.8%
LECOLincoln Electric Holdings, Inc.+109.2%26.4%
RBCRBC Bearings Incorporated+98.9%33.7%
CLHClean Harbors, Inc.+168.5%28.4%
SWKStanley Black & Decker, Inc.−30.8%37.6%
ARMKAramark+117.1%28.8%

Data and methodology

Returns are total returns from month‑end adjusted closing prices (dividends reinvested) through Oct 30, 2026. Crisis drawdowns and trailing maximum drawdowns use daily prices. Analyst coverage counts ratings published in the last 12 months, shown with a 30‑day delay. Full method: Exent methodology.

Company data as of Oct 20, 2026. The move around an earnings report runs from the close before it to the close after it; a price target counts as hit when the stock closed at or beyond it within 12 months (Exent analyst data). Revenue by region and segment, share counts and executive pay come from company filings; insider trades from SEC Form 4, short interest from FINRA, institutional ownership from 13F filings, Congress trades from STOCK Act disclosures filed with the House and Senate, federal contracts from USAspending.gov. Filings from the last 30 days are shown as counts only.

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Check CHRW with Exent Gems

Wall Street’s average CHRW price target is 29.7% above the latest share price. See what the best‑ranked analysts on CHRW say now in Exent Gems.

  1. Exent ranks Wall Street analysts by their past price‑target hit rate and returns, and keeps the best‑ranked few.
  2. Gems shows who the top‑ranked analysts covering CHRW are, their live calls and the median target of only the top‑rated analysts.
  3. Gems flags the stocks where several top‑ranked analysts agree: a starting point for your own research, not a promise.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

No. CHRW returned +131.2% (+8.7% a year) over the 10 years to Oct 30, 2026, versus +316.3% (+15.3% a year) for the S&P 500, including dividends.

Yes. As of Oct 20, 2026, CHRW (C.H. Robinson Worldwide, Inc.) is one of the 503 stocks in the S&P 500.

No. As of Oct 20, 2026, CHRW (C.H. Robinson Worldwide, Inc.) is not one of the 101 stocks in the Nasdaq-100.

CHRW fell −43.4% from peak to trough during the global financial crisis (2007–09), versus −56.5% for the S&P 500.

CHRW fell −19.7% from peak to trough during the covid crash (feb–mar 2020), versus −34.1% for the S&P 500.

CHRW fell −21.3% from peak to trough during the 2022 inflation bear market, versus −25.4% for the S&P 500.

Over the 5 years to Oct 30, 2026, CHRW’s Sharpe ratio was 0.27 and its Sortino ratio 0.42, versus 0.58 and 0.91 for the S&P 500.

CHRW’s 5‑year annualized volatility was 34.9%, higher than the S&P 500’s 17.0%, with a beta of 0.95.

Among large US stocks, the lowest correlations with CHRW over the last 60 months were INTU (−0.17), CME (−0.16), NOW (−0.12). Its correlation with long Treasuries (TLT) was 0.29 and with gold (GLD) 0.21.

CHRW beat the consensus earnings-per-share estimate in 11 of its last 12 quarterly reports through Jul 29, 2026, and the revenue estimate in 3 of 12. The stock moved 9.9% on average, up or down, from the close before each report to the close after it.

Yes. As of Oct 20, 2026, 5 members of Congress had disclosed 34 trades in CHRW (24 buys and 10 sales) in STOCK Act disclosures filed with the House and Senate.

As of the Sep 30, 2026 settlement date, 4.69% of CHRW’s float was sold short (5.5 million shares, 3.9 days to cover), according to FINRA short-interest reports. A year earlier it was 6.60%.

No. CHRW’s diluted share count fell 10.8% over the five fiscal years to fiscal 2025 and rose 0.7% in the latest year. Stock-based compensation was 0.5% of revenue, and buybacks totaled $354.7 million.

What do the best‑ranked analysts say on CHRW now?

Exent ranks Wall Street analysts by their track record. Gems shows who the top‑ranked analysts on CHRW are, their latest calls and the stocks where several of them agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.